Covalent targeted radioligands potentiate radionuclide therapyXi‐Yang Cui, Zhu Li, Ziren Kong et al.|Nature|2024Cited by 165
CTR-FAPI PET Enables Precision Management of Medullary Thyroid CarcinomaZiren Kong, Shaoyan Liu, Han Li et al.|Cancer Discovery|2024Cited by 23
A Bis‐Boron Amino Acid for Positron Emission Tomography and Boron Neutron Capture TherapyJunyi Chen, Zhibo Liu, Mengxin Xu et al.|Angewandte Chemie International Edition|2024Cited by 17
Covalent FAPI PET enables accurate management of medullary thyroid carcinoma: A prospective single-arm comparative clinical trial.Ziren Kong, Shaoyan Liu, Li Zhu et al.|Journal of Clinical Oncology|2024Cited by 1
Publisher Correction: Covalent targeted radioligands potentiate radionuclide therapyXi‐Yang Cui, Zhu Li, Ziren Kong et al.|Nature|2025Cited by 1